Quant System Drives Stock Outperformance Through Disciplined Metrics
TL;DR
- Quant Z-scores translate financial metrics into academic letter grades, simplifying sector comparisons and providing an instant characterization of metric strength or weakness.
- Merck slightly outperforms Pfizer due to superior momentum (B- vs. C) and growth (A- vs. A), despite Pfizer having a more attractive valuation (A vs. B-).
- Comfort Systems' hold rating persists despite strong growth and profitability (A grades) because its valuation metrics are poor (F grade), indicating it is very expensive relative to its sector.
- Diversification is key to minimizing risk and maximizing returns, with a strategy to scale back any single stock position exceeding 15% to approximately 10%.
- Energy stocks' performance is highly sensitive to oil prices and broader economic conditions like recessions or interest rate changes, requiring careful navigation of upstream, downstream, and refiner segments.
- Holding stocks with a "hold" rating, even after price appreciation, is advisable if they still offer a good yield, as a hold is not a sell signal unless the rating degrades to sell or strong sell.
- Quant analysis, similar to GARP, assesses stocks on value, growth, profitability, momentum, and EPS revisions, weighting underlying metrics based on their predictive value.
Deep Dive
Steven Cress of Seeking Alpha's Head of Quant team emphasizes that a robust quant system, like the one used for "Alpha Picks," prioritizes a disciplined, data-driven approach to stock selection and management, leading to significant outperformance compared to the broader market. The core implication is that consistent application of quantitative metrics, even when faced with market volatility or individual stock price fluctuations, allows investors to mitigate risk and achieve superior long-term returns by focusing on fundamental strength and strategic rebalancing.
The analysis of specific stocks like Credo Technology and Comfort Systems illustrates how quant ratings are derived from multiple underlying metrics, such as momentum, growth, profitability, and valuation, each weighted according to its historical predictive value. For instance, Credo Technology maintains a strong momentum rating despite recent stock stagnation because its 12-month performance (up 101%) and other shorter-term periods significantly outpace its sector. Conversely, Comfort Systems, despite excellent growth and profitability grades (A), is rated a "hold" due to an "F" in valuation, underscored by its forward PE being nearly double the sector average, demonstrating that strong fundamentals alone do not guarantee a buy rating if valuation is excessively stretched. The Z-score methodology, used to standardize financial metrics against sector averages and translate them into easy-to-understand letter grades (A-F), is central to this process, providing an instant characterization of a stock's relative strength or weakness.
Furthermore, Cress highlights that quant ratings can shift as fundamentals change, particularly in sensitive sectors like energy, where external factors such as oil prices directly impact stock valuations and ratings. He advises investors to hold onto stocks with "hold" ratings if they still offer a good yield and solid fundamentals, as a "hold" is distinct from a "sell" or "strong sell." Rebalancing is also crucial, with a practice of reducing any position exceeding 15% of the portfolio to 10% to maintain diversification and minimize risk, a strategy that Cress himself employs by equal-weighting his top 10 picks. The consistent outperformance of these quant-selected stocks, with multi-year returns significantly exceeding the S&P 500, reinforces the long-term benefits of adhering to a disciplined quantitative investment strategy, emphasizing monthly investing regardless of market sentiment and a focus on fundamental quality, even during periods of high market appreciation or decline.
Action Items
- Create GARP screener: Define criteria for B- or above factor grades in value, growth, profitability, momentum, and EPS revisions.
- Audit valuation metrics: For 3-5 high-growth stocks, compare forward PE, EV/Sales, and PEG ratios against sector averages.
- Implement diversification check: For any single position exceeding 15%, scale back to 10% to manage risk.
- Track 5-10 key energy stock sensitivities: Monitor oil price correlation and recessionary indicators for sector navigation.
- Draft runbook for quant metric changes: Outline process for evaluating and adjusting stock ratings based on metric shifts.
Key Quotes
"We use a Z-score for all the financial metrics, whether it's PE or revenue growth or EPS growth or EBITDA growth. What goes into a Z-score is you're taking the absolute data point for that metric versus the average or a median data point for the sector, and you create a ratio out of it, and that becomes the Z-score."
Steven Cress explains that a Z-score is a ratio comparing a specific financial metric's data point to the sector's average or median. This metric is used across various financial indicators within their quantitative analysis.
"So when you look at that grade, it shows you, it gives you an instant characterization of how that metric compares to the rest of the sector. So it could be an A, it could be a B, it could be a C, or it could be an F, and that tells you if that particular metric is strong or weak."
Steven Cress clarifies that the Z-score is translated into an academic letter grade (A-F) to provide an immediate understanding of a metric's performance relative to its sector peers. This grading system offers a quick assessment of whether a metric is strong or weak.
"The difference we see though is momentum for Merck is a B minus where Pfizer is a C, and the EPS revisions are both B. So it's basically winning by a nose. They're very close, but Merck just beats it slightly on the momentum basis."
Steven Cress highlights that Merck slightly outperforms Pfizer in their quantitative analysis, specifically on the momentum factor, which is rated B- for Merck compared to C for Pfizer. While both stocks have strong overall quant grades, Merck's edge in momentum is a key differentiator.
"Even though the growth is really strong and the profitability is strong, the stock is very expensive. If you look at it on a PE forward basis, the trailing PE is 42 times versus the sector at 21 times. The forward PE is 38 times versus the sector at 20 times."
Steven Cress explains that Comfort Systems receives a "hold" rating despite strong growth and profitability due to its significantly high valuation metrics. He provides specific PE ratios for Comfort Systems, showing them to be roughly double those of the sector average.
"So we're looking for stocks that are collectively strong on value, growth, profitability, momentum, and EPS revisions. Those are the factors that are important to our quant system."
Steven Cress outlines the core factors his quantitative system prioritizes when assessing stocks. These key areas include value, growth, profitability, momentum, and earnings per share (EPS) revisions, which collectively inform their stock selection process.
"But a diverse portfolio helps to minimize your risk and maximize your returns, and it's important to do it on a consistent basis."
Steven Cress emphasizes the importance of diversification in portfolio management for both risk reduction and return maximization. He advises that consistent application of investment discipline, such as regular investing, is crucial regardless of market conditions.
Resources
External Resources
Articles & Papers
- "top stocks for the new year for 2026" (investing experts) - Excerpted from a webinar and to be posted on investing experts.
- "top 10 stocks for 2026" (seeking alpha) - Mentioned as an article Steve Cress published.
People
- Steven Cress - Head of quant, author of "top stocks for the new year for 2026" and "top 10 stocks for 2026".
- Steve Cress - Mentioned for his quant methodology and top stock picks.
Organizations & Institutions
- Credo Technology - Mentioned as a stock pick with a high momentum rating.
- Pfizer - Mentioned in comparison to Merck for stock metrics and management.
- Merck - Mentioned as a stock pick with strong quant factor grades, particularly momentum.
- Energy Transfer - Mentioned as an example of a stock that moved from a strong buy to a hold due to changing fundamentals.
- Comfort Systems - Mentioned as a stock with strong growth and profitability but a poor valuation, resulting in a hold rating.
- S&P 500 - Used as a benchmark for stock returns.
Websites & Online Resources
- Seeking Alpha - Platform where Steve Cress publishes articles and where users can follow him.
- Investing Experts - Platform where an excerpt from a webinar will be posted.
Other Resources
- Z score - A metric used for financial data points compared to sector averages to create a grade.
- GARP (Growth at a Reasonable Price) - A methodology that looks for stocks strong in value, growth, profitability, momentum, and EPS revisions.
- Alpha Picks - A service or portfolio that has specific rules for holding and selling stocks.
- PQP - Mentioned in relation to Steve Cress's offerings.